Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients

Liver International - Tập 24 Số 6 - Trang 588-594 - 2004
Nadya Kagansky1, Shmuel Levy, Daniel Keter, Ephraim Rimon, Zhomicky Taiba, Zvi Fridman, David L. Berger, Hilla Knobler, Stephen Malnick
1Department of Geriatric Medicine, Kaplan-Harzfeld Medical Center, Rehovot, Israel. [email protected]

Tóm tắt

Kagansky N, Levy S, Keter D, Rimon E, Taiba Z, Fridman Z, Berger D, Knobler H, Malnick S. Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients. 
Liver International 2004: 24: 588–594. © Blackwell Munksgaard 2004Abstract: Background: Non‐alcoholic fatty liver disease (NAFLD), a common entity in the general population, has been shown to be linked with insulin resistance and metabolic syndrome. Several of the components of the metabolic syndrome are more common in the aged population. The aims of the current study were to determine in the aged, the prevalence and the clinical presentation of NAFLD, as well as the relation to the underlying metabolic abnormalities.Method: In this prospective study, we evaluated 91 octogenarians with a mean age of 85.56±3.76 years, who were admitted to the rehabilitation departments of a geriatric hospital. Clinical evaluation included: abdominal ultrasound (US), fasting glucose and lipid levels, serum liver enzymes, ferritin, iron and transferrin saturation. Elderly patients with NAFLD were compared with 46 young patients with NAFLD.Results: NAFLD diagnosed by US was a common finding in this aged population, is present in 42/91 patients (46.2%). No significant differences were observed between the patients with or without NAFLD in the following: age, gender, chronic illnesses, anthropometric parameters, lipid profile, fasting glucose levels, metabolic syndrome prevalence, serum levels of transaminases, ferritin and iron. Young patients with NAFLD had significantly higher serum levels of triglycerides and a significantly higher prevalence of glucose intolerance, obesity and the metabolic syndrome compared with the elderly patients with NAFLD.Conclusions: NAFLD was a common finding in our group of elderly patients and the prevalence was higher than reported in the general population. In contrast to the well‐described association between the metabolic syndrome and NAFLD in the general population, we did not find this association in the aged group. In addition, none of the patients had stigmata of advanced liver disease. These data suggest that NAFLD is a common and benign finding in the elderly population, but is not associated with the metabolic syndrome.

Từ khóa


Tài liệu tham khảo

10.1053/gast.2002.33573

10.1093/qjmed/92.2.73

10.2214/ajr.145.4.753

10.1007/BF01536033

10.1053/gast.2002.35354

10.3109/00365527709181339

10.1016/S0002-9343(99)00271-5

10.1161/01.CIR.96.1.37

10.1001/jama.285.19.2486

Yajima Y, 1983, Ultrasonographical diagnosis of fatty liver, significance of the liver–kidney contrast, 139, 43

10.2169/internalmedicine1962.27.142

Araujo L M, 1998, Liver and biliary ultrasonography in diabetic and non‐diabetic obese women, Diabetes Metab, 24, 458

Lonardo A, 1997, The bright liver syndrome, prevalence and determinants of a “bright” liver echopattern, 29, 351

10.7326/0003-4819-132-2-200001180-00004

El‐Hassan A Y, 1992, Fatty infiltration of the liver, analysis of prevalence, radiological and clinical features and influence on patient management, 65, 774

NHNES 3, 1993, Declining total cholesterol levels among US adults. The National Health and Nutrition Surveys, JAMA, 269, 3002, 10.1001/jama.1993.03500230084034

Lipid Research Clinics, 1980, Population Studies Data Boo, vol 1: The Prevalence Study, DHHS (NIH), 80, 1527

10.1001/jama.287.3.356

The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group, 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension, final results of SHEP, 265, 3255

National Diabetes Data Group, 1995, Diabetes in America

Day C P, 1998, Steatohepatiti, a tale of two “hits”?, 114, 842

10.1056/NEJM200011163432007

10.1002/hep.1840360609

10.1053/gast.2002.34168

National Institutes of Health, 2002, Consensus Development Conference Statement, management of hepatitis C 2002: June 10–12, 2002, 36, S3

Seef L., 2002, Natural history of chronic hepatitis C, Hepatology, 36, S35

Tiechman M, 1987, Alcohol consumption among Israeli adolescents, a decade of research, 24, 281